{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:11:49Z","timestamp":1781277109888,"version":"3.54.1"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,5,22]],"date-time":"2006-05-22T00:00:00Z","timestamp":1148256000000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:p>An evaluation of general antiepileptic treatment patterns and utilization of particular drugs was carried out based on the prevalence study of adult active epilepsy in a sample of the Estonian population. The antiepileptic drugs (AEDs) used, and their doses were recorded and compared with clinical characteristics. Nineteen per cent of the subjects did not take any AED on the prevalence day; 83% of those on medication were taking a single drug, 15% two, and 2% three AEDs. Localization\u2010related symptomatic epilepsies were most frequently treated with AEDs and were also the largest group receiving polytherapy. The most common agent was carbamazepine (68%), followed by barbiturates. Valproate and phenytoin were used much less. The study design and its impact on the interpretation of results is discussed. The percentage of sodium\u2010channel blockers is generally comparable with that reported from other European countries. The small share of valproate is probably a result of the extensive utilization of barbiturates, and is partially related to the age distribution in the study. The high figure of AED\u2010free cases, and small percentage of polytherapy indicates a tendency for undertreatment. Some points for improvement in AED therapy are discussed.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2006.01268.x","type":"journal-article","created":{"date-parts":[[2006,5,22]],"date-time":"2006-05-22T14:38:10Z","timestamp":1148308690000},"page":"465-470","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Use of antiepileptic drugs in Estonia: an epidemiologic study of adult epilepsy"],"prefix":"10.1111","volume":"13","author":[{"given":"A.","family":"\u00d5un","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Haldre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"M\u00e4gi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,5,22]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.4.665"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2003.00682.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6393.645"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1986.tb03603.x"},{"key":"e_1_2_7_6_2","unstructured":"Ker\u00e4nenT Epilepsy in Adults. An Epidemiological Study in Eastern Finland.Thesis. Kupio University (Finland):Department of Neurology 1988."},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1992.tb01690.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb02036.x"},{"key":"e_1_2_7_9_2","first-page":"24","article-title":"Antiepileptic therapy in a general practice population in Northern Ireland","volume":"34","author":"McCluggae JR","year":"1984","journal-title":"The Journal of the Royal College of General Practitioners"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1992.tb03991.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(95)00008-X"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(96)80061-6"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.1.62"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2001.00197.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(02)00184-5"},{"key":"e_1_2_7_16_2","first-page":"8","article-title":"Epidemiological study of the frequency of prescribing antiepileptic drugs","volume":"34","author":"Peytchev L","year":"1992","journal-title":"Folia Medica (Plovdiv)"},{"key":"e_1_2_7_17_2","first-page":"444","article-title":"Antiepileptic drug utilization in out\u2010patients \u2013 a prescribing pattern study","volume":"34","author":"Peytchev L","year":"1996","journal-title":"International Journal of Clinical Pharmacology and therapeutics"},{"issue":"162","key":"e_1_2_7_18_2","first-page":"S24","article-title":"Management of epilepsy in Hungary","volume":"92","author":"Halasz P","year":"1995","journal-title":"Acta Neurologica Scandinavica"},{"key":"e_1_2_7_19_2","volume-title":"Finnish Statistics on Medicines 1997","author":"Finnish National Agency for Medicines and Social Insurance Institution","year":"1998"},{"key":"e_1_2_7_20_2","volume-title":"Drug Consumption in 2000\u20132003","author":"Finnish National Agency for Medicines"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2003.00121.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(02)00234-6"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb00433.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"e_1_2_7_25_2","volume-title":"Guidelines for DDD and ATC Classification","author":"WHO Collaborating Centre for Drugs Statistics Methodology and Nordic Council on Medicines","year":"1996"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601183340308"},{"key":"e_1_2_7_27_2","volume-title":"Clinical Epilepsy","author":"Duncan JS","year":"1995"},{"key":"e_1_2_7_28_2","volume-title":"Contemporary Diagnosis and Management of the Patient with Epilepsy","author":"Leppik IE","year":"2000"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.04501.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.5.632"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2006.01268.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2006.01268.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T12:52:24Z","timestamp":1696942344000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2006.01268.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1111\/j.1468-1331.2006.01268.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01268.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"2006-05-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}